We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The companies that claim law firms violate their copyrights in scientific articles when the firms submit copies of the articles with patent applications to the U.S. Patent and Trademark Office have sought leave to amend their complaint by withdrawing these claims but will move forward with claims that additional copies the firms make infringe the companies’ copyrights
The Food and Drug Administration (FDA) has reopened the comment period for a proposed rule that would establish standards for direct-to-consumer (DTC) TV and radio advertisements relating to side effects of prescription drugs for humans
